Cyclerion Therapeutics, Inc.
USD3.38
+0.02 (+0.60%)
CEO
Regina Graul
IPO Date
2019-03-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.28
Prev. Close
$3.35
Day Low
$3.28
Day High
$3.48
52W Low
$1.03
52W High
$8.48
Market Cap
$0.01B
Volume
0.00M
| -2.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -46.6% | -39.4% | 0.00 | 3.85 | -1.5 |
| 31 Dec 2022 | FY | -1778.5% | -14841.1% | -421.7% | -243.8% | 0.00 | 1.94 | -0.6 |
| 31 Dec 2021 | FY | 100.0% | -1555.6% | -107.0% | -87.0% | 0.00 | 5.00 | -1.3 |
| 31 Dec 2020 | FY | -2357.1% | -3388.6% | -130.8% | -67.4% | 0.77 | 3.45 | -1.2 |
| 31 Dec 2019 | FY | -2010.9% | -2729.3% | -125.9% | -66.0% | 0.76 | 5.55 | -0.6 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 1103.4% | -1557.2% | 0.00 | 0.05 | -3.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 1096.3% | -1717.0% | 0.00 | 0.09 | -3.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 0.00 | -5.4 |
| -1.3 |
| 30 Sept 2025 | Q3 | 100.0% | -111.5% | -10.2% | -9.4% | 0.00 | 5.78 | -1.9 |
| 30 Jun 2025 | Q2 | 100.0% | -348.4% | -3.8% | -3.5% | 0.00 | 5.03 | -6.9 |
| 31 Mar 2025 | Q1 | 100.0% | -1764.2% | -16.3% | -14.5% | 0.00 | 4.21 | -1.1 |
| 31 Dec 2024 | Q4 | 100.0% | 29.3% | 6.0% | 5.5% | 0.00 | 5.83 | 3.9 |
| 30 Sept 2024 | Q3 | 100.0% | -372.7% | -8.8% | -8.1% | 0.00 | 5.07 | -2.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -15.1% | -13.1% | 0.00 | 3.68 | -1.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -15.5% | -13.6% | 0.00 | 4.17 | -1.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -15.0% | -12.7% | 0.00 | 3.85 | -1.2 |